These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8136943)

  • 41. Increased production of interleukin-6 by T lymphocytes from patients with multiple myeloma.
    Lapeña P; Prieto A; Garcia-Suarez J; Reyes E; San Miguel J; Jorda J; Alvarez-Mon M
    Exp Hematol; 1996 Jan; 24(1):26-30. PubMed ID: 8536788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Characterization of autologous-tumor specific cytotoxic T cells induced by means of butanol-extracted soluble antigen from T lymphocytes in colon cancer patients].
    Hamagashira K
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):128-37. PubMed ID: 8464410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of aging on the in vitro response of human lymphocytes to interleukin-2.
    Yamashita N; Suzuki H; Maruyama M; Sugiyama E; Yano S
    Jpn J Med; 1984 Aug; 23(3):211-5. PubMed ID: 6333539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
    Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
    J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro.
    Mangge H; Beaufort F; Neubauer M; Samitz M; Schauenstein K
    Cancer; 1990 Aug; 66(4):677-83. PubMed ID: 2386899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation and proliferation of normal resting human T lymphocytes in serum-free culture: role of IL-4 and IL-6.
    Habetswallner D; Pelosi E; Bulgarini D; Camagna A; Samoggia P; Montesoro E; Giannella G; Lazzaro D; Isacchi G; Testa U
    Immunology; 1988 Nov; 65(3):357-64. PubMed ID: 3264807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
    J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T
    Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes.
    Sfikakis PP; Souliotis VL; Katsilambros N; Markakis K; Vaiopoulos G; Tsokos GC; Panayiotidis P
    Clin Immunol Immunopathol; 1996 Apr; 79(1):43-9. PubMed ID: 8612350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
    Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.
    Sztein MB; Serrate SA; Goldstein AL
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6107-11. PubMed ID: 3090550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient decrease in IL-2-responsive lymphocytes 24 hours after initiation of continuous IL-2 infusion in cancer patients.
    Weil-Hillman G; Hank JA; Rosenthal NS; Sondel PM
    J Biol Response Mod; 1988 Oct; 7(5):424-37. PubMed ID: 3053997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
    Cozzolino F; Torcia M; Carossino AM; Giordani R; Selli C; Talini G; Reali E; Novelli A; Pistoia V; Ferrarini M
    J Exp Med; 1987 Aug; 166(2):303-18. PubMed ID: 2955070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferative response of human CD4+ T lymphocytes stimulated by the lectin jacalin.
    Blasco E; Barra A; Nicolas M; Lecron JC; Wijdenes J; Preud'homme JL
    Eur J Immunol; 1995 Jul; 25(7):2010-8. PubMed ID: 7542601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.